Biote (BTMD) vs Glass House Brands Subordinate Voting Shares (GLAS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Biote (BTMD) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, losing 68.9% versus a loss of 81.8%. Over five years, GLAS leads with a -73.3% price change compared with -91.6% for BTMD. Glass House Brands Subordinate Voting Shares is the larger company by market cap ($118.1 million vs $26.3 million), about 4.5 times the size, while Biote is growing revenue faster (-2.5% vs -9.4%).
Biote converts more of its revenue into profit, with a net margin of 14.1% versus -16.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BTMD | GLAS |
|---|---|---|
| Share price | $0.8147 | $1.18 |
| Market cap | $26.28M | $118.11M |
| 1-day change | -3.56% | -2.48% |
| YTD return | -68.67% | -86.67% |
| 1-year return | -68.90% | -81.82% |
| 5-year return | -91.64% | -73.33% |
| Forward P/E | 3.33 | — |
| EPS (TTM) | $-0.07 | $-0.69 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $192.22M | $181.98M |
| Revenue growth (YoY) | -2.52% | -9.41% |
| Net income (latest FY) | $27.05M | $-29.66M |
| Gross margin | 71.46% | 42.29% |
| Operating margin | 18.50% | -9.08% |
| Net margin | 14.07% | -16.30% |
| 52-week high | $2.90 | $13.93 |
| 52-week low | $0.81 | $1.06 |
| Distance from 52-week high | -71.91% | -91.53% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +220.36% | +465.25% |
| Average volume | 146.21K | 2.02M |
| Shares outstanding | 27.04M | 93.85M |
| Employees | 223 | 357 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Glass House Brands Subordinate Voting Shares is about 4.5 times larger than Biote by market value ($118.11M vs $26.28M).
- BTMD has outperformed GLAS by 12.9 percentage points over the past year.
- Biote is more profitable, keeping 14.1 cents of every revenue dollar as net income versus -16.3 cents for Glass House Brands Subordinate Voting Shares.
- Biote grew revenue faster in its latest fiscal year (-2.52% vs -9.41%).
About Biote
BTMD stock →biote Corp. operates in practice-building business within the hormone optimization space.
Health Care · Medicinal Chemicals and Botanical Products · 223 employees
About Glass House Brands Subordinate Voting Shares
GLAS stock →Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.
Health Care · Medicinal Chemicals and Botanical Products · 357 employees
BTMD vs GLAS FAQ
Which is bigger, Biote or Glass House Brands Subordinate Voting Shares?
Glass House Brands Subordinate Voting Shares (GLAS) is larger, with a market capitalization of $118.11M compared with $26.28M for Biote (BTMD).
Which stock has performed better over the past year, BTMD or GLAS?
BTMD returned -68.90% over the past 12 months, compared with -81.82% for GLAS (price return, excluding dividends). Past performance does not predict future results.
Are Biote and Glass House Brands Subordinate Voting Shares in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.